Focal Therapeutics

Focal Therapeutics is a medical device company that was established to help surgeons, radiation oncologists, and other clinicians to clearly identify a surgical site through the use of an innovative tissue marker.

The company’s BioZorb™ tissue marker is an implantable device placed by surgeons that delineates the site of tissue removal in three dimensions. BioZorb is applicable to virtually all forms of radiation therapy and assists physicians in treatment planning, patient positioning during treatment, and long-term follow-up.

Focal Therapeutics’ leadership team has a long track record in the development and commercialization of medical devices, particularly in the field of breast cancer care. As such, the company has chosen to offer BioZorb initially to surgeons and radiation oncologists who treat breast cancer patients.

Focal Therapeutics headquartered in United States, North America, operates in the Biotechnology, Health Care, Medical, Medical Device, Therapeutics sector. The company focuses on Biotechnology and has secured $465.9M in funding across 40 round(s). With a team of 11-50 employees, Focal Therapeutics is actively contributing to advancements in Biotechnology. Their latest funding round, Venture Round - Focal Therapeutics, raised $7.8M. Discover more about their projects, partnerships, and impact on our platform.